carvedilol has been researched along with atrial natriuretic factor in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lund-Johansen, P; Myking, O; Omvik, P | 1 |
| Demura, H; Imaki, T; Matsuda, Y; Muraki, T; Naruse, K; Naruse, M; Seki, T; Tanabe, A; Yoshimoto, T | 1 |
| Böhm, M; Buikema, H; Flesch, M; Paul, M; Pinto, YM; Teisman, AC; van Gilst, WH | 1 |
| Doughty, R; Espiner, EA; Frampton, C; Ikram, H; Macmahon, S; Nicholls, MG; Richards, AM; Sharpe, N; Yandle, TG | 1 |
| Barth, W; Bauer, M; Deten, A; Leicht, M; Reinohs, M; Zimmer, HG | 1 |
| Fujimura, M; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y | 1 |
| Aizawa, Y; Fuse, K; Hanawa, H; Hirono, S; Ito, M; Kato, K; Kodama, M; Ma, M; Nakazawa, M; Ohta, Y; Tanabe, T; Watanabe, K; Yamamoto, T | 1 |
| Boomsma, F; de Boer, RA; Siebelink, HJ; Tio, RA; van Veldhuisen, DJ | 1 |
| Hanatani, A; Hirooka, K; Hori, M; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y | 1 |
| Abraham, WT; Bristow, MR; Dutcher, D; Ferguson, D; Gilbert, EM; Larrabee, P; Lindenfeld, JA; Linseman, JV; Lowes, BD; Minobe, WA; Quaife, RA; Robertson, AD; Roden, RL; Sederberg, J; Shakar, SF; Volkman, K; Wolfel, EE | 1 |
| Bellorini, M; Desnos, M; Duboc, D; Funck, F; Guillard, N; Jourdain, P; Loiret, J; Thebault, B | 1 |
| Jiang, WP; Liu, ZH; Shen, B; Song, JP | 1 |
| Androne, AS; Hryniewicz, K; Hudaihed, A; Katz, SD | 1 |
| Chan, S; Fung, JW; Nicholls, MG; Richards, AM; Sanderson, JE; Yandle, TG; Yip, G; Yu, CM | 1 |
| Backes, RJ; Bailey, KR; Burnett, JC; Frantz, RP; Grill, D; Hanna, RD; Heublein, D; Mookadam, F; Moualla, SK; Nelson, SM; Nobrega, TP; Olson, LJ | 1 |
| Chen, L; Gu, W; Kong, Y; Li, W; Liu, H; Yang, N | 1 |
| Arsenault, M; Couet, J; Lachance, D; Roussel, E; Zendaoui, A | 1 |
| Abd Elhameed, AG; Abu-Elsaad, NM; El-Karef, A; Ibrahim, TM | 1 |
7 trial(s) available for carvedilol and atrial natriuretic factor
| Article | Year |
|---|---|
Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.
Topics: Arginine Vasopressin; Atrial Natriuretic Factor; Carbazoles; Carvedilol; Double-Blind Method; Heart Failure; Humans; Multivariate Analysis; Myocardial Ischemia; Natriuretic Peptide, Brain; Neuropeptides; Norepinephrine; Predictive Value of Tests; Prognosis; Propanolamines; Survival Analysis; Vasodilator Agents; Ventricular Dysfunction, Left | 1999 |
Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Atrial Natriuretic Factor; Blood Pressure; Carbazoles; Carvedilol; Chronic Disease; Double-Blind Method; Endothelial Growth Factors; Female; Heart Failure; Heart Rate; Humans; Lymphokines; Male; Middle Aged; Propanolamines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Atrial Natriuretic Factor; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Chronic Disease; Female; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Propanolamines; Therapeutic Equivalency; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2001 |
Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype.
Topics: Antihypertensive Agents; Atrial Natriuretic Factor; Biopsy; Calcium-Transporting ATPases; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Catecholamines; Disease Progression; Female; Gene Expression; Heart Ventricles; Humans; Male; Metoprolol; Middle Aged; Myocardium; Myosin Heavy Chains; Phenotype; Propanolamines; Protein Isoforms; Radionuclide Imaging; Receptors, Adrenergic, beta; RNA, Messenger; Sarcoplasmic Reticulum; Ventricular Function, Left | 2002 |
Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atrial Natriuretic Factor; Carbazoles; Carvedilol; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Exercise; Female; Forearm; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Muscle, Skeletal; Natriuretic Peptide, Brain; Norepinephrine; Propanolamines; Prospective Studies; Reference Values; Regional Blood Flow; Vascular Resistance; Vasodilator Agents; Vasomotor System | 2003 |
Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Carbazoles; Carvedilol; Drug Therapy, Combination; Heart Failure; Humans; Metoprolol; Natriuretic Peptide, Brain; Propanolamines; Renin; Ventricular Function, Left | 2003 |
Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Carvedilol; Endothelin-1; Endothelins; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Propanolamines | 2005 |
11 other study(ies) available for carvedilol and atrial natriuretic factor
| Article | Year |
|---|---|
Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Body Fluids; Carbazoles; Cardiac Output; Carvedilol; Catecholamines; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Physical Exertion; Propanolamines | 1992 |
Potentiation of natriuretic peptide action by the beta-adrenergic blocker carvedilol in hypertensive rats: a new antihypertensive mechanism.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Carbazoles; Carvedilol; Cyclic GMP; Hypertension; Male; Propanolamines; Rats; Rats, Inbred SHR; Receptors, Atrial Natriuretic Factor; RNA, Messenger | 1998 |
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Carbazoles; Carvedilol; Heart Function Tests; Hydralazine; Hypertension; Isoquinolines; Losartan; Norepinephrine; Propanolamines; Quinapril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrahydroisoquinolines | 1998 |
Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen.
Topics: Adrenergic Antagonists; Animals; Atrial Natriuretic Factor; Calcium Channel Blockers; Carbazoles; Carrier Proteins; Carvedilol; Collagen; Cytokines; Female; Gene Expression Regulation; Glycoproteins; Hemodynamics; Hypertrophy, Left Ventricular; Interleukin-1; Interleukin-6; Muscle Proteins; Nisoldipine; Norepinephrine; Propanolamines; Protein Isoforms; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ventricular Remodeling | 2000 |
Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Heart Ventricles; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Propanolamines; Radiopharmaceuticals; Recovery of Function; Retrospective Studies; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Function, Left | 2000 |
Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Atrial Natriuretic Factor; Carbazoles; Carvedilol; Guanylate Cyclase; Male; Myocardium; Natriuretic Peptide, Brain; Propanolamines; Rats; Rats, Inbred Lew; Receptors, Atrial Natriuretic Factor; RNA, Messenger | 2000 |
Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Carvedilol; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Follow-Up Studies; France; Furosemide; Heart Failure; Humans; Incidence; Lisinopril; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Severity of Illness Index; Spironolactone; Stroke Volume; Treatment Outcome | 2003 |
[The changes of plasma levels of brain natriuretic peptides in evaluation of treatment responses in chronic heart failure].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Natriuretic Factor; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Immunoradiometric Assay; Male; Metoprolol; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Radioimmunoassay | 2003 |
Immunoregulatory effects of carvedilol on rat experimental autoimmune myocarditis.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atrial Natriuretic Factor; Autoimmune Diseases; Carbazoles; Carvedilol; Cytokines; Enzyme-Linked Immunosorbent Assay; Male; Myocarditis; Organ Size; Propanolamines; Rats; Rats, Inbred Lew; Receptors, Adrenergic, beta-2; RNA, Messenger | 2010 |
Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Aortic Valve Insufficiency; Atrial Natriuretic Factor; Bradycardia; Capillaries; Carbazoles; Carvedilol; Chronic Disease; Disease Models, Animal; Extracellular Matrix Proteins; Follistatin-Related Proteins; Gene Expression Regulation; Heart Rate; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic; RNA, Messenger; Stroke Volume; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Pressure | 2011 |
Yogurt Containing the Probacteria Lactobacillus acidophilus Combined with Natural Antioxidants Mitigates Doxorubicin-Induced Cardiomyopathy in Rats.
Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Camellia sinensis; Carbazoles; Cardiomyopathies; Cardiotonic Agents; Carvedilol; Cholesterol; Cytokines; Daucus carota; Doxorubicin; Functional Food; Heart; Lactobacillus acidophilus; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Oxidative Stress; Probiotics; Propanolamines; Rats, Sprague-Dawley; Yogurt | 2015 |